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TECHNICAL NOTE
Changing patterns of gene expression in developing mouse
kidney, as probed by differential mRNA display combined with
cDNA library screening
NORMAN D. ROSENBLUM and THOMAS D. YAGER
Division of Nephrology, The Hospital Jbr Sick Children, Toronto, Ontario, Canada
The mesenchymal-epithelial (M-E) transformation of the met-
anephric mesenchyme is a process of fundamental importance to
mammalian renal development. It is accompanied by dramatic
changes in gene expression [reviewed in 1]. The goal of this study
is to identify mRNAs that are specifically up-regulated or down-
regulated between different stages of metanephric development,
to further elucidate the molecular mechanisms that underlie early
renal development. Current estimates of the number of genes that
are expressed in a differentiated tissue (approximately 15,000) [2]
suggest that a large number of genes may be differentially
expressed over the course of a developmental event such as
transformation of the metanephric mesenchyme to an epithelium.
To date, only a small subset of the genes that are differentially
expressed during the renal M-E transformation have been iden-
tified [3]. The identification of differentially expressed genes in the
early stage metanephros has in the past been hindered for
technical reasons. Differential library screening or subtractive
cDNA cloning require much greater quantities of mRNA than
can readily be obtained from the early stage metanephros [only 20
ng of poly (A)+ mRNA can be obtained from each murine E10.5
metanephros]. More recently, the isolation of differentially ex-
pressed genes from very small numbers of cells has become much
easier due to the development of differential mRNA display
(dd-PCR) [4—8]. This technique uses the polymerase chain reac-
tion (PCR) to amplify fragments of individual cDNAs from
complex mRNA poois. Compared to subtractive cloning and
differential screening techniques, 10- to 50-fold less mRNA, and
therefore tissue, is required for dd-PCR.
The identification and isolation of differentially expressed genes
by dd-PCR has been limited by one significant drawback of the
procedure itself. Amplified eDNA fragments usually are short and
are derived from the 3' untranslated region of mRNA. Therefore
they usually do not contain protein-coding information [4, 9]. This
limits one's ability to identify Ihe amplified eDNA fragment by
comparison to DNA sequence databases, which to date remain
highly incomplete. Because a very large number of cDNA frag-
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ments can be amplified and cloned in a dd-PCR trial, a general
solution to this problem is desirable.
To address this limitation of dd-PCR, we describe a strategy by
which a large number of differentially displayed eDNA fragments
can be pooled and used as a multiplex probe to screen a total
mouse embryo eDNA library. This allows the isolation of clones
that are likely to contain protein-coding sequence, and therefore
can be positively identified by comparison to sequence databases.
In addition, this approach allows use of a eDNA library prepared
from total mouse embryo mRNA. This eliminates the need to
prepare cDNA libraries from limiting amounts of specific embry-
onic tissues or organs. As an illustration of this approach we have
identified thymosin -i0 as a gene that is expressed de novo during
the metanephric M-E transformation between days E10.5 and
E13 of mouse embryonic development.
Methods
Embryonic metanephroi were harvested from CDI mouse
embryos derived from staged pregnancies. The morning of the
vaginal plug was defined as embryonic day 0 (E0). Embryonic
kidneys were harvested at E10.5 and E13. The E10.5 metanephroi
were uninduced, since the ureteric bud was unbranched and
histologic analysis revealed no evidence of mesenchymal conden-
sation. In contrast, E13 metanephroi were induced since the
ureteric bud had branched several times and there was histologic
evidence of tubulogenesis [10]. Histologic analyses (data not
shown) of harvested E10.5 and E13 metanephroi were consistent
with these definitions. Immediately after isolation metanephroi
were snap-frozen in liquid nitrogen and stored at —80°C.
Poly (A)+ mRNA from a pooi of 14 identically staged meta-
nephroi was isolated by the oligo (dT) method using a commercial
kit (Fast Track; Invilrogen, San Diego, CA, USA). Differential
mRNA display was performed using commercially available re-
agents (GenHunter, Brookline, MA, USA) [4]. Briefly, 200 ng of
DNAse I-treated mRNA was used as a substrate for first strand
eDNA synthesis. This synthesis reaction employed one of four
different deoxynucleotide 5'-T11MN-3' primers in which M is
degenerate and N is either A, T, C or G. The first strand eDNA
was taken directly into amplification by PCR using the same 3'
primer and one of a set of 5' decamer oligodeoxynucleotides (AP
primers) of arbitrarily-defined sequence (Table 1). -[35SJ-dATP
was added as a radioactive tracer in the PCR reaction. Forty
cycles of PCR amplification were performed in a programmable
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Table 1. Differential display of E1O.5 versus E13 metanephric poly
(A)+ mRNA pools using different primer pairs
N bands
3 Primer° amplified from
(deoxynucleotide 5' Primer E13 but not
13-mer) (deoxynucleotide 10-mer) from E10.5
5'-T11 MC-3' AP-2:5'-GACCGCTFGT-3'
AP-4: 5'-GGTACTCCAC-3'
AP-7: 5'-CCGAAGGAAT-3'
AP-9: 5'-CGTGGCAATA-3'
AP-lO: 5'-TAGCAAGTGC-3'
7
5
12
8
6
5'-T11 MT-3' AP-7: 5'-CCGAAGGAAT-3'
AP-8: 5'-GGATVFGTGCG-3'
6
3
5'-T11 MA-3' AP-4: 5'-GGTACTCCAC-3'
AP-5: 5'-G'flI'GCGATCC-3'
9
12
Total number 68
M is a degenerate position (dA, dT, dC and dG)
dri-block (Perkin-Elmer) using the following thermal-cycling pro-
tocol: 94°C for 30 seconds, 40°C for two minutes, and 72°C for 30
seconds. This was followed by incubation at 72°C for an additional
five minutes at the end of the 40 cycles. The amplified cDNAs
were separated in a 0.4 mm thick, 30 cm long 6% polyacrylamide
gel (19:1 acrylamide:bis ratio) and identified by autoradiography.
PCR bands that were differentially amplified between the E10.5
and E13 mRNA pools were isolated from the gel, and reamplified
using the identical PCR conditions by which they were originally
generated [5]. A subset of reamplified PCR bands were cloned by
the TA method into the pCRII vector (Invitrogen).
A multiplex DNA probe was generated by pooling equivalent
amounts of 68 differentially-displayed and reamplified PCR
bands. These PCR bands were selected by the criterion of being
amplified from E13 mRNA but not from ElO mRNA. For plaque
hybridization, fourteen 100 ng aliquots of the multiplex probe
were individually labeled with cs-[32P]-dCTP by the random
priming method [11, 12] to a specific activity of iO cpm//xg DNA.
Labeled DNA was then purified away from unincorporated label
by chromatography through G50 Sephadex. The purified chro-
matographic fractions of probe from the fourteen labeling reac-
tions were pooled. This multiplex probe was then used to screen
400,000 recombinant plaques of an E12 mouse whole embryo
eDNA library in the AEXlox vector (provided by C.C. Hui, The
Hospital for Sick Children, Toronto). The conditions for library
screening were as follows: prehybridization in 5 x SSC (1 x
SSC = 0.15 M NaCI, 0.01 M sodium citrate, pH 7.0), 1% sarkosyl,
20 jxg/ml salmon sperm DNA for 30 minutes at 56°C, hybridiza-
tion for 16 hours at 56°C in the same solution, followed by two
56°C washes with 3 x SSC, 0.5% sarkosyl and two 56°C washes
with 3 x SSC. Positive plaques from the first round of library
screening were replated and subjected to secondary and tertiary
screening, as above.
Inserts from tertiary positives were rescued in the form of
plasmids by infecting E. coli strain BM25.8 with the positive
phage, and then plating bacteria on selective media according to
the manufacturer's instructions (Novagen, Inc.). DNA inserts
were obtained from the resulting plasmids by making minipreps,
followed by PCR using the vector-primers 5'-TGAGGITGTA-
GAAGTTCCG-3' and 5'-GATTTAGGTGACACTATAG-3' at
an annealing temperature of 52°C. Amplified DNA inserts were
sequenced directly by thermal cycle DNA sequencing using a
commercial kit (New England Biolabs). The cycle sequencing
used VentR DNA polymerase and the above vector-primer oh-
godeoxynucleotides. Conventional DNA sequencing was per-
formed by the dideoxy chain termination method using T4 DNA
polymerase (Pharmacia Biotech). DNA sequences were analyzed
by comparison to Genbank and EMBL databases using the
BLAST algorithm.
Reverse transcription-PCR was used to detect mRNAs encod-
ing thymosin 13-10, insulin-like growth factor-i (IGF-1), and
non-muscle myosin light chain 3 (MLC3 nm) in Eil.5 and E13
metanephric mRNA pools. Oligo (dT)-primed first strand eDNA
was synthesized with RNase H reverse transcriptase (Superscript
II, Gibco BRL) using 200 ng poly (A)+ mRNA as a substrate.
PCR reactions were performed using the following primers: (1)
mouse thymosin 13-10, sense primer, 5'-GTAAGAAAATGGCA-
GACAAGCC-3' and antisense primer, 5'-AGTCCGATFAGTG-
GAGGG-3' (Genbank/EMBL accession # Z48496); (2) mouse
IGF-1, sense primer 5'-CTTCACACCTCTFCTACC-3' and anti-
sense primer 5' -AATGCCTGTCTGAGGTGC-3' (Genbank!
EMBL accession # X04482); (3) MLC3 nm, sense primer 5'-
TGGCGAAGAACAAGG-3' and antisense primer 5 '-ATFCAG-
CACCATCCG-3' (Genbank!EMBL accession # U04443). Thirty-
five cycles of amplification were carried out under the following
protocol: 94°C for one minute, 58°C (55°C for MLC3 nm) for two
minutes and 72°C for three minutes.
Results
We performed differential display of Ei0.5 and E13 metaneph-
nc poly (A)+ mRNA with nine different primer pairs (Table 1).
We identified a total of 1500 amplified DNA bands in all our
experiments. This number probably represents —10% of the
mRNAs which are expressed in this tissue and ----1% of all genes
in the mouse genome [2]. While previous reports [4, 5] have
suggested that poly (A) + mRNA may generate smearing of bands
in gels, in replicate experiments using poly (A) + mRNA and
specific primer pairs we observed >95% equivalence in banding
pattern and approximately 50 distinct bands for each primer pair.
Therefore, we do not observe this "smearing" phenomenon. Of
the 1500 bands which we detected on our gels, 29 were amplified
only from the E10.5 metanephric RNA pool, 68 were amplified
only from the E13 metanephric RNA pool, and 1403 were
amplified from both RNA pools. Figure 1 shows a subset of the
bands amplified using the oligodeoxynucleotide primer pair 5'-
T11MC-3' and AP-lO. The solid arrows in the left panel indicate
three bands which are amplified from the E10.5 RNA pool hut not
from the E13 RNA pool. The open arrows in the left panel
indicate six DNA hands that are amplified from the E13 RNA
pool but not from the E10.5 RNA pool. The bands corresponding
to the open arrows were isolated from the gel, reamplified, and
resized on an agarose gel (Fig. 1 B). They were then cloned by the
TA method. The other 68 bands that were amplified from the E13
RNA pool were isolated, rcamplified, and resized in the same
way. Some of these were also cloned.
To determine whether sequencing of the cloned dd-PCR bands
would provide sufficient information to establish their identity, we
sequenced five of the cloned bands, each of which was approxi-
mately 500 bp in size. DNA sequences were compared to the
nonredundant Genbank/EMBL database at both the nucleotide
and six-frame translation level, using the BLAST algorithm. In no
case did this analysis demonstrate a significant match to known
•0
•0
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Fig. 1. Differential mRNA display from E1O.5
and £13 metanephric poly (A) + RNA pools. A.
Autoradiogram of a subset of dd-PCR bands
amplified with deoxynucleotide primers 5'-
T1MC-3' and AP-lO and displayed in a 6%
polyacrylamide gel. The solid arrows indicate
dd-PCR bands which are amplified from the
E10.5 mRNA pool but not from the E13
mRNA pool. The open arrows indicate dd-
PCR bands which are amplified from the E13
mRNA pool but not from the E10.5 niRNA
pool. B. Successful reamplification of dd-PCR
bands that are marked by open arrows in the
polyacrylamide gel (A). Each dd-PCR band
marked by an open arrow in the
polyaciylamide gel was re-amplified and then
displayed in the agarose gel with ethidium
bromide staining. The size of the re-amplified
DNAs is consistent with that predicted from
the polyacrylamide gel.
sequences. The five sequences were then analyzed further with the
GRAIL algorithm [131 to determine if they contained protein
coding information. This additional analysis predicted that coding
sequence was present in only one of the cloned dd-PCR bands.
Our computer analysis is consistent with previous findings that the
products of dd-PCR usually derive from the 3'-untranslated
regions of mRNA [41.
Our dd-PCR experiments thus suggest that approximately 7%
of the mRNAs in the mouse embryonic metanephros (97/1500)
will be differentially expressed between days E10.5 and E13 of
metanephric development. However, this number may be an
overestimate since the number of unique mRNAs which are
represented in our pool of dd-PCR bands may be less than 97.
Our dd-PCR pool could contain redundancies if, for example,
highly abundant mRNAs were amplified in multiple independent
events. Our experiments also suggest that, in general, the identity
of the differentially-amplified bands cannot be established on the
basis of sequence. We reasoned that a useful strategy would be to
pool the dd-PCR hands, and then to use this pool as a complex
probe to screen a A phage eDNA library. Phage eDNA libraries
usually contain clones that range in size from 0.5 Kb to 4 Kb or
more. Since the 3'-untranslated region of an rnRNA typically is
only several hundred base pairs long, there should be a high
probability that such cDNA clones will contain protein-coding
sequence.
To create a usable complex probe by pooling a large number of
dd-PCR hands, it was necessary to define conditions that pro-
duced radioactive labeling to a high specific aetivity. The usual
methods for preparing DNA probes of high specific activity (such
as iO' cpm/j.tg DNA) use approximately 20 ng of a single species
of DNA per labeling reaction [14]. We have determined that a
specific activity  10' cpm/ig could be generated with a pool
containing 68 different dd-PCR bands if approximately 1.4 ng of
each individual band were used in the radiolabeling reaction. The
theory of nucleic acid hybridization [151 predicts that approxi-
mately 140 hours incubation of probe and target should be
required for 50% hybridization to occur using 1.4 ng of a 500 bp
long DNA labeled to a specific activity of 10' cpm/j.tg [t50 = (1/jig
DNA) X (length of DNA probe/5) >< (milliliters of hybridization
mix/iD) X21. To increase the efficiency of detecting positive
plaques on duplicate nylon filter lifts of phage libraries, we
decreased the t50 for hybridization by 10>< by increasing the
concentration of DNA probe by lOx. To ensure a sufficiently high
specific activity, we performed 10 independent DNA labeling
reactions, each with six or seven dd-PCR bands, and then pooled
all labeled DNAs to make the hybridization probe.
The multiplex probe was used to screen —400,000 recombinant
plaques of a phage cDNA library derived from an E12 total mouse
embryo. We identified six different recombinant phage with
inserts ranging in size from 400 bp to 900 bp. The results of DNA
sequencing and comparison to the nonredundant Genbank/
EMBL database arc summarized in Table 2. Positive matches with
a reasonable statistical significance were obtained for three of the
six cDNAs. In particular, the BLAST score of 2.3 x iO'
provided strong evidence that clone 1.1 encodes thymosin -l0.
The identity of clone 1.1 was further defined by aligning its
sequence to that of rat thymosin -10 (Genbank/EMBL Accession
# M17698). This comparison demonstrates that the two se-
quences are identical except for one base pair, 5' of the putative
translation start Site (Fig. 3). The size of a particular eDNA does
not appear to be the factor which determines if a eDNA can be
matched to a sequence in the DNA databank. cDNAs which could
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Table 2. Results of screening 4 >< iO clones from a murine whole
embryo eDNA library with the dd-PCR multiplex probe
Clone
Size of
eDNA Sequence identity*
Probability of random
match to Genbank/
EMBL databasea
1.1 600 bp Thymosin /3-10 2.3 x 10_56
7.3 600 bp Insulin growth factor-i 4.6 X 10-2
3.1 900bp Non-muscle myosin
light chain
8.6 >< iO
4.22 600 bp No significant match —
10.63 600 bp No significant match —
7.6 800 bp No significant match —
a BLAST analysis
(March 11, 1996)
against nonredundant GenbankIEMBL database
not be identified are as large as those which could be identified
(Table 2). This suggests that there exists a qualitative difference
between similar sized dd-PCR bands and cDNAs, viz, cDNAs are
more likely to contain coding information.
To verify whether these three matches are differentially-ex-
pressed in the manner suggested by our dd-PCR results, we
performed RT-PCR on E10.5 and E13 metanephric mRNA using
exact-match primers based on the mouse thymosin /3-10, IGF-1
and MLC3 nm DNA sequences. Using thymosin /3-10 and IGF-1
oligodeoxynucleotide primers, we generated bands of 312 bp and
190 bp, respectively, from an E13 poly (A)+ mRNA pool, but not
from an E10.5 poly (A)+ mRNA pooi (Fig. 2). In contrast, a band
of 270 bp was generated from both mRNA pools using MLC3 nm
oligodeoxynucleotide primers (Fig. 2). Since the expression of
thymosin /3-10 in the developing metanephros has not been
previously reported, the identity of this RT-PCR band was verified
by direct cycle-sequencing of one end of the RT-PCR band.
Comparison of 170 bp of sequence to the published rat thymosin
/3-10 sequence demonstrated that they were identical (Fig. 3).
Discussion
The identification of genes which are up- or down-regulated
during the metanephric M-E transformation has provided impor-
tant insights into the mechanisms which determine renal morpho-
genesis [1, 3]. The murine metanephros is a widely accepted
model for mammalian renal development. However, the very
small quantities of mRNA present in the early murine metane-
phros introduce a serious technical limitation to the isolation of
differentially-expressed genes by the method of differential library
screening. In this context, differential mRNA display (dd-PCR) is
potentially a very useful tool. It should allow very small amounts
of material to be used as a substrate to amplify mRNAs which are
differentially expressed during the M-E transformation, We have
used dd-PCR to study differential mRNA expression in the Ei0.5
and E13 murine metanephros, and we demonstrate both the
advantages and disadvantages of this technique. Using only 100 ng
of poly A+ mRNA from E10.5 and E13 metanephroi we were
able to amplify 1500 eDNA fragments or bands and, furthermore,
identify a subset of 68 bands which were up-regulated or ex-
pressed de novo in the induced metanephros. However, as ex-
pected, these dd-PCR bands were short (<500 bp), and computer
analysis (BLAST and GRAIL) of sequences from five of them did
not reveal the presence of protein-coding sequence. Our inability
to positively identify these dd-PCR bands prevented us from
ranking them in priority for further studies. This problem was
compounded by the large number of dd-PCR bands that were
isolated (N = 68). Therefore, we have developed a method of
creating a complex-sequence probe, by pooling subsets of differ-
entially-amplified PCR bands. Using this approach we have been
able to isolate longer cDNA clones from a mouse total embryo
cDNA library, some of which could be positively identified.
Having made a positive identification, we next could use RT-PCR
with exact-match primers to determine whether a particular
mRNA was, in fact, differentially expressed as suggested by the
initial dd-PCR result.
Our approach also addresses two other recognized limitations
of dd-PCR. (1.) It is not always possible to directly sequence a
dd-PCR band, for example, by cycle-sequencing, since the band
(as defined in the initial 6% polyacrylamide analytical gel) may be
the superimposition of more than one sequence. (2.) A single
species of mRNA may be represented by several differently sized
dd-PCR bands [16]. Our approach of combining dd-PCR bands to
create a multiplex probe, and then using this probe to isolate
cDNA clones from a library, should help overcome these prob-
lems. In a multiplex probe, two identically-sized dd-PCR bands
that differ in sequence will act independently as probes to identify
their matching cDNA clones. Also, multiple dd-PCR bands which
are derived from the same mRNA will contribute additive signals
in a hybridization screen against the matching clone from a cDNA
library.
Our method does not address several previously identified
problems associated with dd-PCR. First, some dd-PCR bands are
false positives for genes that are differentially regulated [9].
However, recent modifications of the dd-PCR method have
lowered the false positive rate [16]. This provides greater confi-
dence that dd-PCR bands identified directly from differential
display, or the corresponding clones isolated from a cDNA library
will correspond to be differentially expressed genes. Second,
dd-PCR bands contain 3'UTRs in preference to coding regions.
While 3'UTRs often encode informative sequence polymor-
phisms useful for genotyping [17], it is often impossible to
establish their sequence identity. This is because DNA databanks
are incomplete at the present time. As a result of the Human
Genome Project, it is expected that all human and mouse gene
sequences will be deposited in the DNA databank within several
years. This will permit the direct identification of sequences which
encode 3'UTRs. But until all 3'UTR sequences are present in the
DNA databank, a method such as ours is needed to bridge the gap
between a 3'UTR (isolated by dd-PCR) and the corresponding
coding sequence (present in the database). In this regard, other
variations of dd-PCR such as "arbitrarily primed RNA finger-
printing" [18] may also be useful. Third, all PCR-based methods
of DNA amplification preferentially identify abundant mRNAs.
This may mitigate against the isolation of less abundant (hence
more novel and interesting) mRNAs [19]. Notwithstanding this
systematic bias in the PCR method, we were able to identify
several mRNAs that arc potentially important for metanephric
development.
Perhaps the greatest benefit of our method is that it allows a
total embryo eDNA library to he used. This circumvents the
problem of having to create a cDNA library from very small
amounts of specialized tissue (such as E13 metanephros). We
note that, in our experiments, a multiplex probe composed of E13
dd-PCR eDNA fragments was used to screen an E12 total embryo
library. The temporal (embryonic stage) mismatch between the
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Fig. 2. Thymosin (3-10 mRNA is differentially expressed in the E13 metanephros. Electrophoretic gel separation of RT-PCR products which were amplified
from E10.5 and E13 poly (A)+ mRNA substrates, using exact-match deoxynucleotide primers for mouse thymosin (3-10, IGF-1 and MLC3 nm. A. A
band of —300 bp is amplified only from E13 metanephric mRNA using thymosin (3-10 primers. B. A band of —190 bp is amplified only from E13
metanephric mRNA using IGF-1 primers. C. A hand of --270 bp is amplified from both E10.5 and E13 metanephric mRNA using MLC3 nm primers.
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Fig. 3. Comparison of DNA sequences of putative
mouse thymosin (3-10 with rat thymosin 13-10. The
partial sequence of eDNA clone 1.1 is compared
with the published sequence of rat thymosin (3-10
(Genbank/EMBL Accession # M17698). The
sequences are identical except for base #8
(highlighted in bold) of clone 1.1. An RT-PCR
band was generated from an E13 metanephric
mRNA pool using exact-match thymosin (3-10
primers and then directly cycle-sequenced. The
sequence (m.thymosin b-b) is compared with the
published sequence of rat thymosin (3-10. The
sequences are identical.
probe and the library, plus the fact that we screened only 400,000
recombinants, may help to explain the relatively small number of
independent eDNA clones that we isolated using our multiplex
probe. Clearly, our method would be optimized by using a mouse
eDNA library that corresponds exactly to the same developmental
stage as the multiplex probe. In our case, such a eDNA library was
not available. The inability to identify 3/6 cDNAs isolated from
the E12 cDNA library is probably explained by the limited
number of mouse coding sequences currently contained within the
DNA datahank. By the time the Human Genome Project is
complete it will be possible to identify all such cDNAs, even on
the basis of a short amount of sequence. Furthermore, with the
help of computer programs which identify evolutionarily con-
served sequence elements [20], it should he possible to apply our
method to other biological species, and then identify the partial
eDNA clones by sequence element homology.
The identification of a eDNA encoding thymosin -10 provides
new insight into the molecular mechanisms that occur during the
metanephric M-E transformation. Thymosin -10 is one member
of a family of genes that encode short acidic proteins (41 to 43
A C
m. clone i.i
r. thymosin b-iO
m. thymosin b-iO
m. clone i.i
r. thymosin b-ia
m. thymosin b-ia
m. clone i.i
r. thymosin b-ia
m. thymosin b-la
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amino acids long), which bind actin monomers and thereby
decrease the rate of growth of actin filaments [21, 22]. The
regulation of actin filaments is a necessary component of cell
shape change including lamillopodia formation. Such cell shape
changes occur during the M-E transformation [10]. Expression of
thymosin f3-10 expression is also positively correlated with meta-
static potential in human melanoma cells [23]. Studies of thymosin
(3-10 expression in the adult and fetal rat have demonstrated that
it is more highly expressed in the fetus [23, 24]. In the kidney,
studies of thymosin J3-10 have previously been limited to E21, just
before birth. Our studies greatly extend these data, and demon-
strate that this mRNA is expressed during the M-E transforma-
tion early in murine renal development. These results suggest that
thymosin 13-10 may function to regulate cell shape change during
early renal morphogenesis.
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